The effectiveness of intensive insulin therapy is being tested in the Diabetes Control and Complications Trial (DCCT). This multicenter, multiyear endeavor represents a vital effort to learn whether tight metabolic control prevents, delays, or reverses chronic complications in patients with type I (insulin-dependent) diabetes. The essence of the DCCT is an unbiased test of the basic foundations underlying the therapeutic approach to type I diabetes. Although we heartily support these efforts, we cannot help wondering why similar energy has not also been directed toward a rigorous test of diet in the treatment of type II (non-insulin-dependent) diabetes.
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The "other" diabetes is a far greater public health problem in Western society, afflicting 8-10 times more individuals than type I diabetes. Most textbooks and almost all diabetologists agree that dietary treatment constitutes the basic cornerstone of care in type II diabetes, whereas exercise, hypoglycemic agents, and insulin are considered second-line or adjunctive therapies. It is generally assumed that diabetic patients either eat too much or consume too many of the wrong foods and that these behaviors help unmask the familiar metabolic abnormalities. Furthermore, it is widely believed that most, if not all, of the aberrations improve or are at least partially reversed by dietary manipulation.
A pressing question is whether dietary modification actually reverses or substantially improves the lot of the type II diabetic patient on a chronic basis. Although many studies demonstrate that various acute dietary interventions improve most metabolic abnormalities of type II diabetes, none have demonstrated the long-term benefits of such corrective therapy. Efforts to undertake these studies have been hampered by high rates of failure and metabolic recidivism.
We are all too familiar with the fact that, although motivated patients can lose weight swiftly, they too often regain it with dispiriting rapidity. Is it possible that the high rate of dietary dereliction reflects, as some authors suggest, an intrinsic defect in energy metabolism or thermogenesis? If so, is this defect really amenable to therapy by dietary or pharmacological means? Is the weight loss-weight regain cycle more dangerous than a stable yet above-ideal body weight? Are the short-term improvements associated with successful dietary intervention just the fleeting expression of dynamic changes in weight and caloric intake? Will such benefits remain after sustained weight maintenance, or will the imbalance between insulin secretion and sensitivity still progress like the relentless immunodestruction of the fi-cell in type I diabetes? In the long term, is sustained dietary change associated with an improvement in the cardiovascular risk and reduction in complication rates in type II diabetes?
Answers to these and more questions are needed before we can confidently offer realistic dietary and therapeutic guidelines to our patients. Like the DCCT for type I diabetes, there is an urgent necessity for a soundly designed, long-range dietary intervention trial that would attempt to establish the pros and cons of nutritional advice and the long-term impact of diet on the most basic abnormalities of type II diabetes. The ethics and feasibility of such a study are matters that need to be determined.
